[CLINICAL EXPERIENCE WITH THE COMBINED APPEARANCE OF TUBERCULOSIS AND VIRUS HEPATITIS].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D003096:Collapse Therapy; D004358:Drug Therapy; D006505:Hepatitis; D006506:Hepatitis A; D006801:Humans; D006854:Hydrocortisone; D010336:Pathology; D011013:Pneumonectomy; D011239:Prednisolone / Q000627:therapeutic use*; D011718:Pyrazinamide; D013223:Statistics as Topic; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary
D000636:Aminosalicylic Acids; D011718:Pyrazinamide; D010131:Aminosalicylic Acid; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D006854:Hydrocortisone
AMINOSALICYLIC ACID; COLLAPSE THERAPY; CORTICOTROPIN, THERAPEUTIC; DRUG THERAPY; HEPATITIS, INFECTIOUS; HYDROCORTISONE; PATHOLOGY; PNEUMONECTOMY; PREDNISOLONE, THERAPEUTIC; PYRAZINAMIDE; STATISTICS; TUBERCULOSIS, PULMONARY
KLINISCHE ERFAHRUNGEN UEBER DAS GEMEINSAME AUFTRETEN VON TUBERKULOSE UND VIRUS-HEPATITIS.